Neurosurgical Product Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Neurosurgical Product Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)


The global market for neurosurgical products has been experiencing robust growth in recent years, a trend expected to persist in the coming years. The notable expansion in developed nations is primarily driven by medical science advancements and state-of-the-art healthcare infrastructures. Efforts by medical device manufacturers to innovate and advance technology have also significantly contributed to market growth.

Increasing Elderly Population Driving Market Demand

The global increase in the elderly population is a major factor propelling the neurosurgical products market. Countries such as China and India are expected to have a larger aging population compared to developed nations like the U.S. Older individuals are at a higher risk of hemorrhages and strokes compared to younger people. The American Heart Association states that the risk of stroke doubles for those over 55 years of age. These factors are poised to significantly drive the global market for neurosurgical products.

Government Funding and Awareness Initiatives Propel Growth

Growing financial support from governments and public health organizations for developing neurosurgical products aims to alleviate the burden of neurological disorders on healthcare systems. Adequate funding enables researchers to develop new treatments for neurological conditions. For instance, the U.S. National Institute of Neurological Disorders and Stroke has significantly increased its grants, demonstrating a commitment to advancing neurosurgical research.

Rising Brain Tumor Incidences Boost Demand for Neurosurgical Products

The increasing incidence of brain tumors is markedly fueling the demand for neurosurgical products. Products like endoscopes and stereotactic radiosurgery systems are extensively used in detecting and removing brain tumors. GLOBOCAN statistics reveal a significant rise in brain tumor cases worldwide. Similarly, the American Brain Tumor Association reports a substantial number of new brain tumor cases, with a notable percentage being malignant. This trend highlights the need for advanced neurosurgical products.

Awareness Campaigns Fueling Market Growth

Rising awareness of neurological disorders is also benefiting the neurosurgical products market. Various governmental and non-governmental organizations worldwide are conducting awareness programs for the early detection of neurological conditions. For example, New Zealand organizes Brain Awareness Week annually, featuring updates and developments from neuroscientists and neurologists. In the U.S., the National Institute of Neurological Disorders and Stroke hosts the Know Stroke campaign each year to spread awareness about stroke symptoms and treatments.

Challenges from Non-surgical Therapies

Despite the promising growth, the market faces challenges due to the availability of alternative treatments for neurological diseases. Drug therapies are often the first treatment option for neurological conditions, with neurosurgery considered only if non-surgical therapies are ineffective. Additionally, stringent regulations and lengthy approval processes for medical devices, particularly stereotactic neurosurgical products, can delay their market availability, posing a challenge to market growth.

Market Keyplaers
• Integra LifeSciences Holdings Corporation
• KARL STORZ GmbH & Co. KG
• Medtronic plc
• Johnson & Johnson Services, Inc.
• Stryker Corporation
• Elekta AB
• Terumo Corporation
• Penumbra, Inc.
• B. Braun Melsungen AG
• Varian Medical Systems, Inc.
• Others

Key Market Segmentation

By Condition
• Hydrocephalus
• Aneurysms
• Arteriovenous malformations
• Pituitary and intracranial tumors

By Procedure
• Open Neurosurgery
• Neurovascular and Minimally Invasive Surgery

By Product Type
• Shunts
• Neurosurgical Endoscope
• Stereotactic Radiosurgery System
• Embolization Products
• Aneurysm and AVM Clips

By Geography
• North America
• Europe
• Asia-Pacific



Please note: Delivery Timelines - 5 working days.


1. Executive Summary
1.1. Global Neurosurgical Product Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2024
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. PESTLE Analysis
3. Global Neurosurgical Product Market Outlook, 2018 – 2031
3.1. Global Neurosurgical Product Market Outlook, by Condition, Value (US$ Bn), 2018 – 2031
3.1.1. Key Highlights
3.1.1.1. Hydrocephalus
3.1.1.2. Aneurysms
3.1.1.3. Arteriovenous malformations
3.1.1.4. Pituitary and intracranial tumors
3.2. Global Neurosurgical Product Market Outlook, by Procedure, Value (US$ Bn), 2018 – 2031
3.2.1. Key Highlights
3.2.1.1. Open Neurosurgery
3.2.1.2. Neurovascular and Minimally Invasive Surgery
3.3. Global Neurosurgical Product Market Outlook, by Product Type, Value (US$ Bn), 2018 – 2031
3.3.1. Key Highlights
3.3.1.1. Shunts
3.3.1.2. Neurosurgical Endoscope
3.3.1.3. Stereotactic Radio-surgery System
3.3.1.4. Embolization Products
3.3.1.5. Aneurysm and AVM Clips
3.4. Global Neurosurgical Product Market Outlook, by Region, Value (US$ Bn), 2018 – 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Neurosurgical Product Market Outlook, 2018 – 2031
4.1. North America Neurosurgical Product Market Outlook, by Condition, Value (US$ Bn), 2018 – 2031
4.1.1. Key Highlights
4.1.1.1. Hydrocephalus
4.1.1.2. Aneurysms
4.1.1.3. Arteriovenous malformations
4.1.1.4. Pituitary and intracranial tumors
4.2. North America Neurosurgical Product Market Outlook, by Procedure, Value (US$ Bn), 2018 – 2031
4.2.1. Key Highlights
4.2.1.1. Open Neurosurgery
4.2.1.2. Neurovascular and Minimally Invasive Surgery
4.3. North America Neurosurgical Product Market Outlook, by Product Type, Value (US$ Bn), 2018 – 2031
4.3.1. Key Highlights
4.3.1.1. Shunts
4.3.1.2. Neurosurgical Endoscope
4.3.1.3. Stereotactic Radio-surgery System
4.3.1.4. Embolization Products
4.3.1.5. Aneurysm and AVM Clips
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Neurosurgical Product Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 – 2031
4.4.1.2. U.S. Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 – 2031
4.4.1.3. U.S. Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 – 2031
4.4.1.4. Canada Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 – 2031
4.4.1.5. Canada Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 – 2031
4.4.1.6. Canada Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 – 2031
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Neurosurgical Product Market Outlook, 2018 – 2031
5.1. Europe Neurosurgical Product Market Outlook, by Condition, Value (US$ Bn), 2018 – 2031
5.1.1. Key Highlights
5.1.1.1. Hydrocephalus
5.1.1.2. Aneurysms
5.1.1.3. Arteriovenous malformations
5.1.1.4. Pituitary and intracranial tumors
5.2. Europe Neurosurgical Product Market Outlook, by Procedure, Value (US$ Bn), 2018 – 2031
5.2.1. Key Highlights
5.2.1.1. Open Neurosurgery
5.2.1.2. Neurovascular and Minimally Invasive Surgery
5.3. Europe Neurosurgical Product Market Outlook, by Product Type, Value (US$ Bn), 2018 – 2031
5.3.1. Key Highlights
5.3.1.1. Shunts
5.3.1.2. Neurosurgical Endoscope
5.3.1.3. Stereotactic Radio-surgery System
5.3.1.4. Embolization Products
5.3.1.5. Aneurysm and AVM Clips
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Neurosurgical Product Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
5.4.1. Key Highlights
5.4.1.1. Germany Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 – 2031
5.4.1.2. Germany Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 – 2031
5.4.1.3. Germany Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 – 2031
5.4.1.4. U.K. Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 – 2031
5.4.1.5. U.K. Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 – 2031
5.4.1.6. U.K. Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 – 2031
5.4.1.7. France Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 – 2031
5.4.1.8. France Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 – 2031
5.4.1.9. France Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 – 2031
5.4.1.10. Italy Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 – 2031
5.4.1.11. Italy Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 – 2031
5.4.1.12. Italy Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 – 2031
5.4.1.13. Turkey Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 – 2031
5.4.1.14. Turkey Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 – 2031
5.4.1.15. Turkey Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 – 2031
5.4.1.16. Russia Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 – 2031
5.4.1.17. Russia Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 – 2031
5.4.1.18. Russia Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 – 2031
5.4.1.19. Rest of Europe Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 – 2031
5.4.1.20. Rest of Europe Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 – 2031
5.4.1.21. Rest of Europe Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 – 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Neurosurgical Product Market Outlook, 2018 – 2031
6.1. Asia Pacific Neurosurgical Product Market Outlook, by Condition, Value (US$ Bn), 2018 – 2031
6.1.1. Key Highlights
6.1.1.1. Hydrocephalus
6.1.1.2. Aneurysms
6.1.1.3. Arteriovenous malformations
6.1.1.4. Pituitary and intracranial tumors
6.2. Asia Pacific Neurosurgical Product Market Outlook, by Procedure, Value (US$ Bn), 2018 – 2031
6.2.1. Key Highlights
6.2.1.1. Open Neurosurgery
6.2.1.2. Neurovascular and Minimally Invasive Surgery
6.3. Asia Pacific Neurosurgical Product Market Outlook, by Product Type, Value (US$ Bn), 2018 – 2031
6.3.1. Key Highlights
6.3.1.1. Shunts
6.3.1.2. Neurosurgical Endoscope
6.3.1.3. Stereotactic Radio-surgery System
6.3.1.4. Embolization Products
6.3.1.5. Aneurysm and AVM Clips
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Neurosurgical Product Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
6.4.1. Key Highlights
6.4.1.1. China Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 – 2031
6.4.1.2. China Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 – 2031
6.4.1.3. China Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 – 2031
6.4.1.4. Japan Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 – 2031
6.4.1.5. Japan Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 – 2031
6.4.1.6. Japan Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 – 2031
6.4.1.7. South Korea Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 – 2031
6.4.1.8. South Korea Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 – 2031
6.4.1.9. South Korea Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 – 2031
6.4.1.10. India Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 – 2031
6.4.1.11. India Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 – 2031
6.4.1.12. India Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 – 2031
6.4.1.13. Southeast Asia Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 – 2031
6.4.1.14. Southeast Asia Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 – 2031
6.4.1.15. Southeast Asia Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 – 2031
6.4.1.16. Rest of Asia Pacific Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 – 2031
6.4.1.17. Rest of Asia Pacific Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 – 2031
6.4.1.18. Rest of Asia Pacific Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 – 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Neurosurgical Product Market Outlook, 2018 – 2031
7.1. Latin America Neurosurgical Product Market Outlook, by Condition, Value (US$ Bn), 2018 – 2031
7.1.1. Key Highlights
7.1.1.1. Hydrocephalus
7.1.1.2. Aneurysms
7.1.1.3. Arteriovenous malformations
7.1.1.4. Pituitary and intracranial tumors
7.2. Latin America Neurosurgical Product Market Outlook, by Procedure, Value (US$ Bn), 2018 – 2031
7.2.1.1. Open Neurosurgery
7.2.1.2. Neurovascular and Minimally Invasive Surgery
7.3. Latin America Neurosurgical Product Market Outlook, by Product Type, Value (US$ Bn), 2018 – 2031
7.3.1. Key Highlights
7.3.1.1. Shunts
7.3.1.2. Neurosurgical Endoscope
7.3.1.3. Stereotactic Radio-surgery System
7.3.1.4. Embolization Products
7.3.1.5. Aneurysm and AVM Clips
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Neurosurgical Product Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
7.4.1. Key Highlights
7.4.1.1. Brazil Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 – 2031
7.4.1.2. Brazil Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 – 2031
7.4.1.3. Brazil Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 – 2031
7.4.1.4. Mexico Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 – 2031
7.4.1.5. Mexico Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 – 2031
7.4.1.6. Mexico Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 – 2031
7.4.1.7. Argentina Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 – 2031
7.4.1.8. Argentina Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 – 2031
7.4.1.9. Argentina Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 – 2031
7.4.1.10. Rest of Latin America Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 – 2031
7.4.1.11. Rest of Latin America Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 – 2031
7.4.1.12. Rest of Latin America Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 – 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Neurosurgical Product Market Outlook, 2018 – 2031
8.1. Middle East & Africa Neurosurgical Product Market Outlook, by Condition, Value (US$ Bn), 2018 – 2031
8.1.1. Key Highlights
8.1.1.1. Hydrocephalus
8.1.1.2. Aneurysms
8.1.1.3. Arteriovenous malformations
8.1.1.4. Pituitary and intracranial tumors
8.2. Middle East & Africa Neurosurgical Product Market Outlook, by Procedure, Value (US$ Bn), 2018 – 2031
8.2.1. Key Highlights
8.2.1.1. Open Neurosurgery
8.2.1.2. Neurovascular and Minimally Invasive Surgery
8.3. Middle East & Africa Neurosurgical Product Market Outlook, by Product Type, Value (US$ Bn), 2018 – 2031
8.3.1. Key Highlights
8.3.1.1. Shunts
8.3.1.2. Neurosurgical Endoscope
8.3.1.3. Stereotactic Radio-surgery System
8.3.1.4. Embolization Products
8.3.1.5. Aneurysm and AVM Clips
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Neurosurgical Product Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
8.4.1. Key Highlights
8.4.1.1. GCC Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 – 2031
8.4.1.2. GCC Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 – 2031
8.4.1.3. GCC Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 – 2031
8.4.1.4. South Africa Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 – 2031
8.4.1.5. South Africa Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 – 2031
8.4.1.6. South Africa Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 – 2031
8.4.1.7. Egypt Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 – 2031
8.4.1.8. Egypt Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 – 2031
8.4.1.9. Egypt Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 – 2031
8.4.1.10. Nigeria Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 – 2031
8.4.1.11. Nigeria Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 – 2031
8.4.1.12. Nigeria Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 – 2031
8.4.1.13. Rest of Middle East & Africa Neurosurgical Product Market by Condition, Value (US$ Bn), 2018 – 2031
8.4.1.14. Rest of Middle East & Africa Neurosurgical Product Market by Procedure, Value (US$ Bn), 2018 – 2031
8.4.1.15. Rest of Middle East & Africa Neurosurgical Product Market by Product Type, Value (US$ Bn), 2018 – 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Product vs Indication Heatmap
9.2. Company Market Share Analysis, 2024
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Integra LifeSciences Holdings Corporation
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. KARL STORZ GmbH & Co. KG.
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Medtronic plc
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Johnson & Johnson Services, Inc.
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Stryker Corporation
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Elekta AB
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Terumo Corporation
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Penumbra, Inc.
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Others
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings